Sigrun Hallmeyer

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Patient Reported

Ejection Fraction

Prognostic Factors

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Joanne M Jeter, Lisa A Kottschade, Robert R McWilliams, Nikhil I Khushalani, Sekwon Jang, Sigrun Hallmeyer, David H McDermott, Hussein A Tawbi, Min Che, Cho-Han Lee, Corey Ritchings, Trong Kim Le, Boas Park, Scott D Ramsey
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study. Immunotherapy (2023)
Merve Hasanov, Denái R Milton, William H Sharfman, Bret Taback, Lee D Cranmer, Gregory A Daniels, Lawrence Flaherty, Sigrun Hallmeyer, Mohammed M Milhem, Lynn G Feun, Ralph J Hauke, Gary Doolittle, Nancy Gregory, Sapna Pradyuman Patel
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. Oncoimmunology 10 (1) (2021)